As a new anti-cancer drug delivery method heads into phase I clinical trials, researchers explore the tissue-level mechanisms that make it work.
By understanding transmission of acoustic waves through microstructure in an individual’s skull, non-invasive ultrasound imaging of the brain and delivery of therapy could be possible in a greater number of people.